Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis

Efficacy of tibial nerve block, local steroid injection or both in the treatment of plantar heel pain syndrome.

Foot (Edinburgh, Scotland)·2010

The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis.

The Journal of antimicrobial chemotherapy·2009

The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.

Rheumatology (Oxford, England)·2008

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.

Rheumatology (Oxford, England)·2007

Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres.

Rheumatology (Oxford, England)·2007

The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs.

Musculoskeletal care·2007

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Correlation of H. pylori Antigen Titer with Digital Polymerase Chain Reaction Quantification: Analytical Evaluation of Cultured, Inactivated Isolates.

Journal of visualized experiments : JoVE·2026

ALK-positive large B-cell lymphoma with plasmacytoid predominance and a novel CEP128::ALK fusion.

Virchows Archiv : an international journal of pathology·2026

Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness.

Journal of clinical medicine·2026

Primary Erythrophagocytic Low-Grade Splenic T-Cell Lymphoma in a Cat: Clinical Case and Literature Review.

Animals : an open access journal from MDPI·2026

Ki-67 Proliferation Index Improves the Prognostic Stratification Accuracy of International Staging System in Newly Diagnosed Multiple Myeloma.

Cancers·2026

Hidden Signals in Serum Protein Electrophoresis: Artificial Intelligence from Laboratory Pattern Recognition to Clinical Validation.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Videos

Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis

Related Concept Videos

Efficacy of tibial nerve block, local steroid injection or both in the treatment of plantar heel pain syndrome.

The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis.

The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.

Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres.

The influence of medication beliefs and other psychosocial factors on early discontinuation of disease-modifying anti-rheumatic drugs.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Correlation of H. pylori Antigen Titer with Digital Polymerase Chain Reaction Quantification: Analytical Evaluation of Cultured, Inactivated Isolates.

ALK-positive large B-cell lymphoma with plasmacytoid predominance and a novel CEP128::ALK fusion.

Critical Episodes of Inflammation, Catabolism, and Immunosuppression Define Mortality Risk in Chronic Critical Illness.

Primary Erythrophagocytic Low-Grade Splenic T-Cell Lymphoma in a Cat: Clinical Case and Literature Review.

Ki-67 Proliferation Index Improves the Prognostic Stratification Accuracy of International Staging System in Newly Diagnosed Multiple Myeloma.

Hidden Signals in Serum Protein Electrophoresis: Artificial Intelligence from Laboratory Pattern Recognition to Clinical Validation.

Related Experiment Videos

Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis

Related Concept Videos

Related Articles